Most studies of CALR mutations were performed on JAK2 mutation-negative MPN patients, and at present, there is little information about the coexistence of the JAK2 V617F mutation and CALR exon 9 mutations [13–18]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.